Header Logo

Connection

STEPHANIE FETZKO to Risk Assessment

Back to Details
This is a "connection" page, showing publications STEPHANIE FETZKO has written about Risk Assessment.
STEPHANIE FETZKO
Connection Strength
0.016
Risk Assessment
  1. Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with (131)I-metaiodobenzylguanidine. Eur J Cancer. 2016 10; 66:144-52.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.